Literature DB >> 32007534

Thirty-Day Morbidity after Simultaneous Resection of Colorectal Cancer and Colorectal Liver Metastasis: American College of Surgeons NSQIP Analysis.

Rebecca A Snyder1, Scarlett Hao2, William Irish2, Emmanuel E Zervos2, Janet E Tuttle-Newhall2, Alexander A Parikh3.   

Abstract

BACKGROUND: Approximately 20% of patients with colorectal cancer (CRC) present with synchronous liver metastases (CRLM). The decision to resect simultaneously or sequentially remains controversial. The primary aim of this study was to determine whether simultaneous resection of CRC and CRLM is associated with increased complications compared to isolated resection. STUDY
DESIGN: Prospective data from the American College of Surgeons (ACS) NSQIP, including the ACS NSQIP procedure-specific colectomy and hepatectomy modules from 2014 to 2017, were reviewed in a retrospective cohort study. Primary study outcome was combined 30-day complication rates; secondary outcomes included colectomy and hepatectomy-specific complication. Multivariable logistic regression was performed to control for confounding factors associated with postoperative complication.
RESULTS: A total of 23,643 patients underwent colectomy, 7,462 hepatectomy, and 592 simultaneous resection for CRC and CLRM. Overall morbidity was higher among patients treated with simultaneous resection (29.9%) compared with either isolated colorectal (22.2%) or hepatic resection (17.1%; p < 0.001). Additionally, postoperative ileus (36.4% vs 19.1%) and anastomotic failure (7.9% vs 3.8%) were more common after simultaneous resection compared with colorectal resection (p < 0.05). Similarly, rates of bile leak (8.3% vs 6.2%, p = 0.195) and post-hepatectomy liver failure (8.7% vs 3.8%, p < 0.001) were higher after simultaneous resection compared with isolated hepatectomy. By multivariable logistic regression, simultaneous resection was associated with increased overall complication compared with isolated colon (odds ratio 1.64 [95% CI 1.36 to 1.96]) or liver resection (odds ratio 2.11 [95% CI 1.75 to 2.55]), as well as increased procedure-specific complication.
CONCLUSIONS: Although simultaneous resection offers definitive resection for patients with synchronous CRC and CRLM, it is associated with significantly increased 30-day overall and procedure-specific postoperative morbidity.
Copyright © 2020 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32007534     DOI: 10.1016/j.jamcollsurg.2019.12.018

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  8 in total

1.  Increased Morbidity and Mortality After Hepatectomy for Colorectal Liver Metastases in Frail Patients is Largely Driven by Worse Outcomes After Minor Hepatectomy: It's Not "Just a Wedge".

Authors:  Natasha Leigh; Gregory A Williams; Steven M Strasberg; Ryan C Fields; William G Hawkins; Chet W Hammill; Dominic E Sanford
Journal:  Ann Surg Oncol       Date:  2022-05-20       Impact factor: 4.339

2.  Identification of RORγ as a favorable biomarker for colon cancer.

Authors:  Xiaofei Pan; Bao Li; Gan Zhang; Yuyong Gong; Rui Liu; Benxin Chen; Yang Li
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

3.  Primary Tumor Resection for Rectal Cancer With Unresectable Liver Metastases: A Chance to Cut Is a Chance for Improved Survival.

Authors:  Jia-Nan Chen; Sami Shoucair; Zheng Wang; Joseph R Habib; Fu-Qiang Zhao; Jun Yu; Zheng Liu; Qian Liu
Journal:  Front Oncol       Date:  2021-03-15       Impact factor: 6.244

4.  Impact of Postoperative Infectious Complications on Long-Term Outcomes for Patients Undergoing Simultaneous Resection for Colorectal Cancer Liver Metastases: A Propensity Score Matching Analysis.

Authors:  Qichen Chen; Yiqiao Deng; Jinghua Chen; Jianjun Zhao; Xinyu Bi; Jianguo Zhou; Zhiyu Li; Zhen Huang; Yefan Zhang; Xiao Chen; Hong Zhao; Jianqiang Cai
Journal:  Front Oncol       Date:  2022-01-07       Impact factor: 6.244

5.  Improved Outcomes of Thermal Ablation for Colorectal Liver Metastases: A 10-Year Analysis from the Prospective Amsterdam CORE Registry (AmCORE).

Authors:  Robbert S Puijk; Madelon Dijkstra; Bente A T van den Bemd; Alette H Ruarus; Sanne Nieuwenhuizen; Bart Geboers; Florentine E F Timmer; Evelien A C Schouten; Jan J J de Vries; Bram B van der Meijs; Karin Nielsen; Rutger-Jan Swijnenburg; M Petrousjka van den Tol; Kathelijn S Versteeg; Birgit I Lissenberg-Witte; Hester J Scheffer; Martijn R Meijerink
Journal:  Cardiovasc Intervent Radiol       Date:  2022-05-18       Impact factor: 2.797

6.  The Impact of Postoperative Complications on Survival after Simultaneous Resection of Colorectal Cancer and Liver Metastases.

Authors:  Sorin Tiberiu Alexandrescu; Narcis Octavian Zarnescu; Andrei Sebastian Diaconescu; Dana Tomescu; Gabriela Droc; Doina Hrehoret; Vladislav Brasoveanu; Irinel Popescu
Journal:  Healthcare (Basel)       Date:  2022-08-19

7.  The Role of Preoperative Platelet-to-Lymphocyte Ratio as a Predictor for Incisional Hernias after Hand-Assisted Laparoscopic Liver Surgery for Metastatic Colorectal Cancer.

Authors:  Ahmad Mahamid; Omar Abu-Zaydeh; Muneer Sawaied; Natalia Goldberg; Riad Haddad
Journal:  J Pers Med       Date:  2022-03-18

8.  Liver-First Approach for Synchronous Colorectal Metastases: Analysis of 7360 Patients from the LiverMetSurvey Registry.

Authors:  Felice Giuliante; Luca Viganò; Agostino M De Rose; Darius F Mirza; Réal Lapointe; Gernot Kaiser; Eduardo Barroso; Alessandro Ferrero; Helena Isoniemi; Santiago Lopez-Ben; Irinel Popescu; Jean-Francois Ouellet; Catherine Hubert; Jean-Marc Regimbeau; Jen-Kou Lin; Oleg G Skipenko; Francesco Ardito; René Adam
Journal:  Ann Surg Oncol       Date:  2021-07-01       Impact factor: 5.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.